Dexamethasone price index

Dexamethasone price December 2025 and outlook (see chart below)

• India:US$515.59/KG, -1.7% down

Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.

Dexamethasone price index

This post is a summary of the Dexamethasone price developments. The price developments of Dexamethasone are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Dexamethasone price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.

The outlook for Dexamethasone prices is generated from different inputs including:

• Very recent price developments of immediate cost drivers of Dexamethasone prices
• Recent price developments of underlying feedstocks which drive the price of Dexamethasone
• Market futures for both cost drives and feedstocks of Dexamethasone prices
• Adjustment of current supply/demand imbalances in the Dexamethasone market
• Longer term trends in likely demand conditions

What is Dexamethasone and what is it used for

Dexamethasone is a synthetic glucocorticoid (a potent corticosteroid) used to reduce inflammation and suppress immune responses. Clinically it is used for a wide range of indications including inflammatory and autoimmune diseases (for example rheumatoid disorders and severe asthma), as an antiemetic and adjunct in cancer chemotherapy, to reduce cerebral and spinal cord oedema in brain tumours or cord compression, and in certain infections (for example as adjunctive therapy in bacterial meningitis and, for selected severe COVID-19 patients, to reduce respiratory deterioration). It is available in multiple formulations (oral, injectable, topical, ophthalmic, and implant forms).

How is Dexamethasone produced

Dexamethasone is produced by multi-step chemical synthesis from steroid precursors; typical routes involve modifying a pregnane steroid framework (introducing the 9α-fluoro and 16α-methyl substitutions and forming the required 1,4-diene-3,20-dione core), with subsequent functional group transformations to give dexamethasone or its salts/esters (for example dexamethasone acetate or dexamethasone sodium phosphate). Pharmaceutical manufacturers then convert the active pharmaceutical ingredient (API) into finished products (tablets, injectable solutions, eye drops, implants) using standard formulation, sterile-fill (for injectables) and quality control processes; detailed alternative synthesis and formulation methods are also described in patents and specialist literature.

How large is the global market for Dexamethasone

Market research reports estimate the dexamethasone market in the hundreds of millions to low billions of US dollars annually, with recent reports (2023–2025) giving figures in the roughly USD ~0.8–1.5 billion range for the dexamethasone/CAS-50-02-2 market and projecting steady growth driven by ongoing demand for corticosteroids, respiratory indications and use in severe COVID-19 management during prior years. Different commercial market reports use different scopes and definitions (API vs finished products, inclusion of related formulations), so estimates vary between publishers.

Where is Dexamethasone produced

Dexamethasone API and finished products are manufactured worldwide. Large volumes of API are produced by specialist API manufacturers in India and China, alongside production by contract and integrated manufacturers in the United States and Europe (including established pharmaceutical companies and contract manufacturers such as Pfizer CentreOne and numerous Indian API producers). Finished product manufacturing and regulatory approvals are distributed across major pharmaceutical markets (India, China, Europe, USA and others), and many global generic manufacturers and contract-manufacturing organisations supply dexamethasone to international markets.